Find information on thousands of medical conditions and prescription drugs.

Telmisartan

Telmisartan is an angiotensin II receptor antagonist (ARB). It is marketed by Boehringer Ingelheim under the tradename Micardis®. Telmisartan is also marketed by Glaxo Group Ltd under the trademark Pritor®. ARBs are prescribed primarily in the treatment of hypertension.

New studies suggest that telmisartan may also have PPARγ agonistic properties that could potentially confer beneficial metabolic effects. This observation is currently being explored in clinical trials.

Home

Tacrine

Tagamet

Talwin

Tamiflu

Tao

Tarka

Taurine

Taxol

Tazorac

Temodar

Tenex

Tenuate

Theo-24

Theobid

Tiazac

Tikosyn

Timolol

Topamax

Tora

Toradol

Trental

Trest

Tretinoin

Triacetin

Triad

Triamcinolone

Triamcinolone hexacetonide

Tricor

Trimox

Tritec

Tubocurarine chloride

Tussionex

Tylenol

Tyrosine

Read more at Wikipedia.org

• [List your site here Free!]

Correction - To: "Spironolactone in Left-Sided Heart Failure: How Does It Fit In?" in October 15, 2001 issue, page 1393
From American Family Physician, 6/1/02

The article "Spironolactone in Left-Sided Heart Failure: How Does It Fit In?" (October 15, 2001, page 1393) contained an error in Table 4 on page 1397. In the column titled "Comments on specific drug," the entry "Increases concentration of digoxin" pertains to telmisartan (Micardis) rather than to candesartan (Atacand). The corrected version of the table is available on the AFP Web site at www.aafp.org/afp/20011015/1393.html.

Return to Telmisartan

Home

Contact

Resources

Exchange Links

ebay